Pro-Dex, Inc. (PDEX)
62.58
+1.18
(+1.92%)
USD |
NASDAQ |
Sep 02, 16:00
62.99
+0.41
(+0.66%)
Pre-Market: 09:13
Pro-Dex Research and Development Expense (Annual) : 3.636M for June 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| June 30, 2025 | 3.636M |
| June 30, 2024 | 3.189M |
| June 30, 2023 | 2.804M |
| June 30, 2022 | 2.98M |
| June 30, 2021 | 4.384M |
| June 30, 2020 | 2.301M |
| June 30, 2019 | 1.882M |
| June 30, 2018 | 1.893M |
| June 30, 2017 | 1.225M |
| June 30, 2016 | 1.204M |
| June 30, 2015 | 1.668M |
| June 30, 2014 | 1.429M |
| June 30, 2013 | 1.79M |
| June 30, 2012 | 2.068M |
| Date | Value |
|---|---|
| June 30, 2011 | 2.416M |
| June 30, 2010 | 2.48M |
| June 30, 2009 | 2.791M |
| June 30, 2008 | 2.732M |
| June 30, 2007 | 2.474M |
| June 30, 2006 | 2.009M |
| June 30, 2005 | 1.74M |
| June 30, 2004 | 1.79M |
| June 30, 2003 | 1.457M |
| June 30, 2002 | 1.545M |
| June 30, 2001 | 1.672M |
| June 30, 2000 | 1.668M |
| June 30, 1999 | 1.70M |
| June 30, 1998 | 1.410M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.889B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.27M |
| AtriCure, Inc. | 90.17M |
| Baxter International, Inc. | 503.00M |